Agilent, CambTEK Ink Sample Prep Tech Co-marketing Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies will co-market CambTEK's extraction and sample prep technologies with its own liquid phase separation, life science, and chemical analysis instruments and software, the companies said today.

Under the agreement, the partners will co-market CambTEK's Rapid Extraction System (RES) for automated sample preparation alongside the Agilent instruments and software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.